Monomorphic Ventricular Tachycardia
5
0
0
2
Key Insights
Highlights
Success Rate
67% trial completion
Treatment Research
7 treatments under study, led by Conventional Vt Ablation
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
20.0%
1 terminated out of 5 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)
Using Ripple Mapping to Guide Substrate Ablation of Scar Related Ventricular Tachycardia.
Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia
Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients With St. Jude Medical (SJM) Implantable Cardioverter Defibrillator (ICD) Systems or Cardiac Resynchronization Therapy Defibrillation (CRT-D) Systems.
Research Network
Common Treatments
- Conventional Vt Ablation1
- Cardiac Catheter Ablation With Icdcrtd1
- Icdcrtd With Nips Or Ep Study1
- Antiarrhythmic Drug1
- Ripple Mapping Guided Vt Ablation1
Active Sponsors
- Abbott Medical Devices2
- Hospital General Universitario Gregorio Marañon1
- Imperial College London1
- Adagio Medical1
Top Investigators
Hospital General Universitario Gregorio Marañon
Imperial College Healthcare NHS Trust
University of Pennsylvania
Texas Cardiac Arrhythmia Research Foundation
Related Conditions
- Myocardial Infarction1
- Dilated Cardiomyopathy1